
### [NCIT:C9291](http://purl.obolibrary.org/obo/NCIT_C9291)
**Label:** Anal Carcinoma

**Subclasses:** [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96551](http://purl.obolibrary.org/obo/NCIT_C96551) (Anal Canal Small Cell Neuroendocrine Carcinoma), [NCIT:C7469](http://purl.obolibrary.org/obo/NCIT_C7469) (Anal Canal Squamous Cell Carcinoma), [NCIT:C133787](http://purl.obolibrary.org/obo/NCIT_C133787) (Anal Canal Cancer by AJCC v6 and v7 Stage), [NCIT:C96553](http://purl.obolibrary.org/obo/NCIT_C96553) (Anal Canal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C5600](http://purl.obolibrary.org/obo/NCIT_C5600) (Anal Adenocarcinoma), [NCIT:C7489](http://purl.obolibrary.org/obo/NCIT_C7489) (Anal Canal Carcinoma), [NCIT:C6873](http://purl.obolibrary.org/obo/NCIT_C6873) (Stage IV Anal Canal Cancer AJCC v6 and v7), [NCIT:C8256](http://purl.obolibrary.org/obo/NCIT_C8256) (Anal Basaloid Carcinoma), [NCIT:C7470](http://purl.obolibrary.org/obo/NCIT_C7470) (Anal Verrucous Carcinoma), [NCIT:C133800](http://purl.obolibrary.org/obo/NCIT_C133800) (Stage III Anal Cancer AJCC v8), [NCIT:C5606](http://purl.obolibrary.org/obo/NCIT_C5606) (Anal Mucinous Adenocarcinoma), [NCIT:C133804](http://purl.obolibrary.org/obo/NCIT_C133804) (Stage IV Anal Cancer AJCC v8), [NCIT:C5609](http://purl.obolibrary.org/obo/NCIT_C5609) (Anal Glands Adenocarcinoma), [NCIT:C133794](http://purl.obolibrary.org/obo/NCIT_C133794) (Anal Cancer by AJCC v8 Stage), [NCIT:C133795](http://purl.obolibrary.org/obo/NCIT_C133795) (Stage 0 Anal Cancer AJCC v8), [NCIT:C6925](http://purl.obolibrary.org/obo/NCIT_C6925) (Anal Margin Squamous Cell Carcinoma), [NCIT:C137857](http://purl.obolibrary.org/obo/NCIT_C137857) (Refractory Anal Carcinoma), [NCIT:C27681](http://purl.obolibrary.org/obo/NCIT_C27681) (Human Papillomavirus-Related Anal Squamous Cell Carcinoma), [NCIT:C5598](http://purl.obolibrary.org/obo/NCIT_C5598) (Paget Disease of the Anus), [NCIT:C7776](http://purl.obolibrary.org/obo/NCIT_C7776) (Stage III Anal Canal Cancer AJCC v6 and v7), [NCIT:C133796](http://purl.obolibrary.org/obo/NCIT_C133796) (Stage I Anal Cancer AJCC v8), [NCIT:C5612](http://purl.obolibrary.org/obo/NCIT_C5612) (Metastatic Anal Canal Carcinoma), [NCIT:C133797](http://purl.obolibrary.org/obo/NCIT_C133797) (Stage II Anal Cancer AJCC v8), [NCIT:C7476](http://purl.obolibrary.org/obo/NCIT_C7476) (Paget Disease of the Anal Margin), [NCIT:C7794](http://purl.obolibrary.org/obo/NCIT_C7794) (Stage 0 Anal Canal Cancer AJCC v6 and v7), [NCIT:C7775](http://purl.obolibrary.org/obo/NCIT_C7775) (Stage II Anal Canal Cancer AJCC v6 and v7), [NCIT:C9037](http://purl.obolibrary.org/obo/NCIT_C9037) (Stage I Anal Canal Cancer AJCC v6 and v7), [NCIT:C7477](http://purl.obolibrary.org/obo/NCIT_C7477) (Paget Disease of the Anal Canal), [NCIT:C7472](http://purl.obolibrary.org/obo/NCIT_C7472) (Anal Margin Carcinoma), [NCIT:C7471](http://purl.obolibrary.org/obo/NCIT_C7471) (Anal Canal Adenocarcinoma), [NCIT:C7793](http://purl.obolibrary.org/obo/NCIT_C7793) (Recurrent Anal Canal Carcinoma), [NCIT:C7474](http://purl.obolibrary.org/obo/NCIT_C7474) (Anal Extramucosal (Perianal) Adenocarcinoma), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), [NCIT:C9161](http://purl.obolibrary.org/obo/NCIT_C9161) (Anal Squamous Cell Carcinoma), [NCIT:C96549](http://purl.obolibrary.org/obo/NCIT_C96549) (Anal Canal Neuroendocrine Carcinoma), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40327](http://purl.obolibrary.org/obo/NCIT_C40327) (Vulvar Cellular Angiofibroma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40326](http://purl.obolibrary.org/obo/NCIT_C40326) (Vulvar Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40321](http://purl.obolibrary.org/obo/NCIT_C40321) (Vulvar Liposarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40320](http://purl.obolibrary.org/obo/NCIT_C40320) (Vulvar Alveolar Soft Part Sarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40318](http://purl.obolibrary.org/obo/NCIT_C40318) (Vulvar Leiomyosarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40314](http://purl.obolibrary.org/obo/NCIT_C40314) (Vulvar Trichoepithelioma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40312](http://purl.obolibrary.org/obo/NCIT_C40312) (Vulvar Nodular Hidradenoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 39.52%


